FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2943679080> ?p ?o ?g. }

• W2943679080 endingPage "672" @default.
• W2943679080 startingPage "665" @default.
• W2943679080 abstract "Summary Objective To evaluate clinical and economic outcomes associated with the use of isavuconazole as antifungal prophylaxis in high‐risk immunocompromised patients. Patients/Methods Retrospective, single‐centre cohort study of patients who received isavuconazole prophylaxis. Outcomes assessed included breakthrough IFI , early discontinuation of isavuconazole for any reason and antifungal prophylaxis prescribed at discharge. The impact on inpatient drug expenditure was evaluated using current isavuconazole and posaconazole drug costs per observed isavuconazole days of therapy ( DOT ) during the study period. Results One hundred thirty‐eight courses of isavuconazole prophylaxis were administered to 98 inpatients (2193 DOT ). Relapsed/refractory acute myelogenous leukaemia was the indication for prophylaxis in over half (59.4%) of patients. Breakthrough IFI occurred in 8 (5.8%) courses. Suspected drug‐related toxicities led to early discontinuation in 6 (4.3%) courses (five hepatotoxicity, one drug rash). At discharge, 24 (17.4%) courses lacked insurance coverage for isavuconazole. The formulary switch to isavuconazole prophylaxis resulted in an estimated mean drug cost savings of $128.25 per DOT relative to estimated posaconazole costs ( P < 0.001). Conclusion Isavuconazole may be an option for antifungal prophylaxis in high‐risk immunocompromised adults and has the potential to produce significant inpatient drug cost savings. Further studies are needed to confirm the clinical efficacy and cost‐effectiveness of isavuconazole in this role." @default.
• W2943679080 created "2019-05-09" @default.
• W2943679080 creator A5030155907 @default.
• W2943679080 creator A5049457451 @default.
• W2943679080 creator A5057165734 @default.
• W2943679080 creator A5076074693 @default.
• W2943679080 date "2019-05-23" @default.
• W2943679080 modified "2023-10-18" @default.
• W2943679080 title "Isavuconazole to prevent invasive fungal infection in immunocompromised adults: Initial experience at an academic medical centre" @default.
• W2943679080 cites W1988385266 @default.
• W2943679080 cites W1989345554 @default.
• W2943679080 cites W2017926403 @default.
• W2943679080 cites W2024259942 @default.
• W2943679080 cites W2039768199 @default.
• W2943679080 cites W2061438827 @default.
• W2943679080 cites W2101785863 @default.
• W2943679080 cites W2115179464 @default.
• W2943679080 cites W2123859227 @default.
• W2943679080 cites W2150628820 @default.
• W2943679080 cites W2154336328 @default.
• W2943679080 cites W2166734004 @default.
• W2943679080 cites W2171456100 @default.
• W2943679080 cites W2189861011 @default.
• W2943679080 cites W2226796591 @default.
• W2943679080 cites W2296337564 @default.
• W2943679080 cites W2507731994 @default.
• W2943679080 cites W2573464562 @default.
• W2943679080 cites W2594511239 @default.
• W2943679080 cites W2619901201 @default.
• W2943679080 cites W2732950461 @default.
• W2943679080 cites W2750285027 @default.
• W2943679080 cites W2768244393 @default.
• W2943679080 cites W2795029464 @default.
• W2943679080 cites W2883412836 @default.
• W2943679080 cites W2883843857 @default.
• W2943679080 cites W2926310234 @default.
• W2943679080 doi "https://doi.org/10.1111/myc.12924" @default.
• W2943679080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31050373" @default.
• W2943679080 hasPublicationYear "2019" @default.
• W2943679080 type Work @default.
• W2943679080 sameAs 2943679080 @default.
• W2943679080 citedByCount "26" @default.
• W2943679080 countsByYear W29436790802019 @default.
• W2943679080 countsByYear W29436790802020 @default.
• W2943679080 countsByYear W29436790802021 @default.
• W2943679080 countsByYear W29436790802022 @default.
• W2943679080 countsByYear W29436790802023 @default.
• W2943679080 crossrefType "journal-article" @default.
• W2943679080 hasAuthorship W2943679080A5030155907 @default.
• W2943679080 hasAuthorship W2943679080A5049457451 @default.
• W2943679080 hasAuthorship W2943679080A5057165734 @default.
• W2943679080 hasAuthorship W2943679080A5076074693 @default.
• W2943679080 hasConcept C100406419 @default.
• W2943679080 hasConcept C121332964 @default.
• W2943679080 hasConcept C126322002 @default.
• W2943679080 hasConcept C142424586 @default.
• W2943679080 hasConcept C16005928 @default.
• W2943679080 hasConcept C167135981 @default.
• W2943679080 hasConcept C177713679 @default.
• W2943679080 hasConcept C2777071850 @default.
• W2943679080 hasConcept C2778566413 @default.
• W2943679080 hasConcept C2778570526 @default.
• W2943679080 hasConcept C2778715236 @default.
• W2943679080 hasConcept C2779548794 @default.
• W2943679080 hasConcept C71924100 @default.
• W2943679080 hasConcept C87355193 @default.
• W2943679080 hasConcept C98274493 @default.
• W2943679080 hasConceptScore W2943679080C100406419 @default.
• W2943679080 hasConceptScore W2943679080C121332964 @default.
• W2943679080 hasConceptScore W2943679080C126322002 @default.
• W2943679080 hasConceptScore W2943679080C142424586 @default.
• W2943679080 hasConceptScore W2943679080C16005928 @default.
• W2943679080 hasConceptScore W2943679080C167135981 @default.
• W2943679080 hasConceptScore W2943679080C177713679 @default.
• W2943679080 hasConceptScore W2943679080C2777071850 @default.
• W2943679080 hasConceptScore W2943679080C2778566413 @default.
• W2943679080 hasConceptScore W2943679080C2778570526 @default.
• W2943679080 hasConceptScore W2943679080C2778715236 @default.
• W2943679080 hasConceptScore W2943679080C2779548794 @default.
• W2943679080 hasConceptScore W2943679080C71924100 @default.
• W2943679080 hasConceptScore W2943679080C87355193 @default.
• W2943679080 hasConceptScore W2943679080C98274493 @default.
• W2943679080 hasIssue "8" @default.
• W2943679080 hasLocation W29436790801 @default.
• W2943679080 hasLocation W29436790802 @default.
• W2943679080 hasOpenAccess W2943679080 @default.
• W2943679080 hasPrimaryLocation W29436790801 @default.
• W2943679080 hasRelatedWork W1988525224 @default.
• W2943679080 hasRelatedWork W2010459370 @default.
• W2943679080 hasRelatedWork W2069529010 @default.
• W2943679080 hasRelatedWork W2113155732 @default.
• W2943679080 hasRelatedWork W2120560034 @default.
• W2943679080 hasRelatedWork W2148310476 @default.
• W2943679080 hasRelatedWork W2921711631 @default.
• W2943679080 hasRelatedWork W2991620731 @default.
• W2943679080 hasRelatedWork W3205839342 @default.
• W2943679080 hasRelatedWork W902067359 @default.
• W2943679080 hasVolume "62" @default.

• next